Fluorescent Protein Fusion Expression System

download Fluorescent Protein Fusion Expression System

of 17

Transcript of Fluorescent Protein Fusion Expression System

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    1/17

    All l Bi t h I t d i C t Eff ti t R h

    Fluorescent Protein

    Fusion Expression System

    For Research Use Only. Not for Diagnostic or Therapeutic Use. Purchase does not include or carry any right to resell or transferthis product either as a stand-alone product or as a component of another product. Any use of this product other than the permitteduse without the express written authorization of Allele Biotech is strictly prohibited

    Box 1 | Product List

    Fluorescent Protein Vectors

    Vector Name Cat. Number

    PagepmWasabi-C ABP-FP-WCNCS 2pmWasabi-N ABP-FP-WNNCS 3pmTFP1-C ABP-FP-TCNCS 4pmTFP1-N ABP-FP-TNNCS 5pLanRFP-C ABP-FP-RCNCS 6pLanRFP-N ABP-FP-RNNCS 7pLanYFP-C ABP-FP-YCNCS 8pLanYFP-N ABP-FP-YNNCS 9Vectors w/ Puromycin Resistance

    pmWasabi-C-Puro ABP-FP-WCNCS 10pmWasabi-N-Puro ABP-FP-WNNCS 11pmTFP1-C-Puro ABP-FP-TCNCS 12pmTFP1-N-Puro ABP-FP-TNNCS 13pLanRFP-C-Puro ABP-FP-RCNCS 14pLanRFP-N-Puro ABP-FP-RNNCS 15pLanYFP-C-Puro ABP-FP-YCNCS 16pLanYFP-N-Puro ABP-FP-YNNCS 17

    IMPORTANT NOTICE TO PURCHASER:These products may be subjects of pendingU.S. and foreign patents. Allele Biotech grants

    academic/government research institutions aworldwide, non-exclusive, royalty-free, limited

    license to use this product for non-commercial

    life science research use only. Such license

    specifcally prohibits the right to sell or otherwise

    transfer this product or its derivatives to a third

    party.

    Industry For-Proft Institutions: Institutions that

    wish to use this product are required to obtain asub-licensing agreement from Allele Biotech. For

    more information please visit Fluorescent Protein

    Sublicense, or contact us via phone or email.

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    2/17

    CMV Promoter ........ 1-589

    Multiple Cloning Sites ........ 591-646

    mWasabi GFP ........ 653-1363

    SV40 poly(A) Signal ........ 1529-1579

    Ampicillin Resistance Gene ........ 2207-3067

    pUC Origin ........ 3216-3858

    Sequencing Primer:

    CMV-F and mWasabi-R(ABP-FP-WASRPRM)

    pmWasabi-CT (ABP-FP-WCNCS)

    Multiple Cloning Sites

    541 ACGGTGGGAG GTCTATATAA GCAGAGCTGG TTTAGTGAAC CGTCAGATCC GCTAGCTCTA

    R * L *

    601 GACTGGATCC TCGAATTCGG TACCTCAAGC TTGCGGCCGC CTCGAGGCCA CCATGGTGAG

    T G S S N S V P Q A C G R L E A T M V S

    661 CAAGGGCGAG GAGACCACAA TGGGCGTAAT CAAGCCCGAC ATGAAGATCA AGCTGAAGAT

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1321 GGCCCGCAAC TCCACCGACG GCATGGACGA GCTGTACAAG TAA

    NheI

    BamHI EcoRI KpnI HindIII NotI XhoI

    C

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    3/17

    CMV Promoter ........ 1-595

    mWasabi GFP ........ 613-1320

    Multiple Cloning Sites ........ 1321-1414

    SV40 poly(A) Signal ........ 1560-1610

    Ampicillin Resistance Gene ........ 2238-3098

    pUC Origin ........ 3247-3889

    Sequencing Primer:

    mWasabi-F(ABP-FP-WASFPRM) and SV40pA-R

    pmWasabi-NT (ABP-FP-WNNCS)

    Multiple Cloning Sites

    601 CCGGTCGCCA CCATGGTGAG CAAGGGCGAG GAGACCACAA TGGGCGTAAT CAAGCCCGAC

    661 ATGAAGATCA AGCTGAAGAT GGAGGGCAAC GTGAATGGCC ACGCCTTCGT GATCGAGGGC

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1261 ACCGTTTACG AGATCGCCGT GGCCCGCAAC TCCACCGACG GCATGGACGA GCTGTACAAGT V Y E I A V A R N S T D G M D E L Y K

    1321 TCCGGACTCA GATCTCGAGT CGGATCCTCG AATTCGGTAC CCTCTAGACA AGCTTGCGGC CGCTAA

    S G L R S R V G S S N S V P S R Q A C G R

    BglII XhoI BamH1 EcoRI KpnI HindIII NotI

    N

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    4/17

    CMV Promoter ........ 1-589

    Multiple Cloning Sites ........ 591-646

    mTFP1 TFP ........ 653-1363

    SV40 poly(A) Signal ........ 1529-1579

    Ampicillin Resistance Gene ........ 2207-3067

    pUC Origin ........ 3216-3858

    Sequencing Primer:CMV-F and mTFP1-R(ABP-FP-TFPRPRM)

    Multiple Cloning Sites

    pmTFP1-CT (ABP-FP-TCNCS)

    541 ACGGTGGGAG GTCTATATAA GCAGAGCTGG TTTAGTGAAC CGTCAGATCC GCTAGCTCTA

    601 GACTGGATCC TCGAATTCGG TACCTCAAGC TTGCGGCCGC CTCGAGGCCA CCATGGTGAG

    661 CAAGGGCGAG GAGACCACAA TGGGCGTAAT CAAGCCCGAC ATGAAGATCA AGCTGAAGAT

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1261 CATCGAGATC CTGAACCACG ACAAGGACTA CAACAAGGTG ACCGTTTACG AGAGCGCCGT

    1321 GGCCCGCAAC TCCACCGACG GCATGGACGA GCTGTACAAG TAA

    C

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    5/17

    601 CCGGTCGCCA CCATGGTGAG CAAGGGCGAG GAGACCACAA TGGGCGTAAT CAAGCCCGAC

    661 ATGAAGATCA AGCTGAAGAT GGAGGGCAAC GTGAATGGCC ACGCCTTCGT GATCGAGGGC

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1261 ACCGTTTACG AGAGCGCCGT GGCCCGCAAC TCCACCGACG GCATGGACGA GCTGTACAAG

    1321 TCCGGACTCA GATCTCGAGT CGGATCCTCG AATTCGGTAC CCTCTAGACA AGCTTGCGGC

    1381 CGCTAA

    CMV Promoter ........ 1-595

    mTFP1 TFP ........ 613-1320

    Multiple Cloning Sites ........ 1321-1414

    SV40 poly(A) Signal ........ 1560-1610

    Ampicillin Resistance Gene ........ 2238-3098

    pUC Origin ........ 3247-3889

    Sequencing Primer:mTFP1-F(ABP-FP-TFPFPRM) and SV40pA-R

    Multiple Cloning Sites

    pmTFP1-NT (ABP-FP-TNNCS)

    N

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    6/17

    541 ACGGTGGGAG GTCTATATAA GCAGAGCTGG TTTAGTGAAC CGTCAGATCC GCTAGCTCTA

    601 GACTGGATCC TCGAATTCGG TACCTCAAGC TTGCGGCCGC CTCGAGGCCA CCATGGTGAG

    661 CAAGGGCGAG GAGGATAACA TGGCCCCTCT CCCAGCAACC CACGATTTAC ACATCTCCGG

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1261 CGTGTTCCGC AAGGTGGAAC TCAAGCACAC CAAGACTGAG CTCAACTTCA AGCAGTGGCA

    1321 GAAGGCATTC CAGGACATCG CCGGCATGGA CGAGCTGTAC AAGTAA

    CMV Promoter ........ 1-589

    Multiple Cloning Sites ........ 591-646

    LanRFP ........ 653-1366

    SV40 poly(A) Signal ........ 1532-1582

    Ampicillin Resistance Gene ........ 2210-3070

    pUC Origin ........ 3219-3861

    Sequencing Primer:CMV-F and LanRFP-R(ABP-FP-RFPRPRM)

    Multiple Cloning Sites

    pLanRFP-CT (ABP-FP-RCNCS)

    C

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    7/17

    601 CCGGTCGCCA CCATGGTGAG CAAGGGCGAG GAGGATAACA TGGCCCCTCT CCCAGCAACC

    661 CACGATTTAC ACATCTCCGG CTCAATCAAT GGACATGAGT TTGACTTGGA AGGCAGTGGC

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1261 CTCAACTTCA AGCAGTGGCA GAAGGCATTC CAGGACATCG CCGGCATGGA CGAGCTGTAC

    1321 AAGAGATCTC GAGTCGGATC CTCGAATTCG GTACCCTCTA GACAAGCTTG CGGCCGCTAA

    CMV Promoter ........ 1-595

    LanRFP ........ 613-1323

    Multiple Cloning Sites ........ 1324-1377

    SV40 poly(A) Signal ........ 1554-1604

    Ampicillin Resistance Gene ........ 2232-3092

    pUC Origin ........ 3241-3883

    Sequencing Primer:LanRFP-F(ABP-FP-RFPFPRM) and SV40pA-R

    Multiple Cloning Sites

    pLanRFP-NT (ABP-FP-RNNCS)

    N

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    8/17

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    9/17

    661 CCGGTCGCCA CCATGGTGAG CAAGGGCGAG GAGGATAACA TGGCCTCTCT CCCAGCGACA

    721 CATGAGTTAC ACATCTTTGG CTCCTTCAAC GGTGTGGACT TTGACATGGT GGGTCGTGGC

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1321AACTTCAAGG AGTGGCAAAA GGCCTTTACC GATGTGATGG GCATGGACGA GCTGTACAAG

    1381 AGATCTCGAG TCGGATCCTC GAATTCGGTA CCCTCTAGAC AAGCTTGCGG CCGCTAA

    CMV Promoter ........ 1-595

    LanYFP ........ 613-1323

    Multiple Cloning Sites ........ 1324-1377

    SV40 poly(A) Signal ........ 1554-1604

    Ampicillin Resistance Gene ........ 2232-3092

    pUC Origin ........ 3241-3883

    Sequencing Primer:LanYFP-F(ABP-FP-YFPFPRM) and SV40pA-R

    Multiple Cloning Sites

    pLanYFP-NT (ABP-FP-YNNCS)

    N

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    10/17

    CMV Promoter ........ 1-589

    Multiple Cloning Sites ........ 591-646

    mWasabi GFP ........ 653-1363

    SV40 poly(A) Signal ........ 1529-1579

    PGK Promoter ........ 1657-2159

    Puromycin Resistance Gene ........ 2242-2841

    SV40 poly(A) signal ........ 2965-3191

    Ampicillin Resistance Gene ........ 3841-4701

    pUC Origin ........ 4850-5492

    Sequencing Primer:

    CMV-F and mWasabi-R(ABP-FP-WASRPRM)

    pmWasabi-CT-PuroR (ABP-FP-WCNCSP)

    541 ACGGTGGGAG GTCTATATAA GCAGAGCTGG TTTAGTGAAC CGTCAGATCC GCTAGCTCTA

    601 GACTGGATCC TCGAATTCGG TACCTCAAGC TTGCGGCCGC CTCGAGGCCA CCATGGTGAG

    661 CAAGGGCGAG GAGACCACAA TGGGCGTAAT CAAGCCCGAC ATGAAGATCA AGCTGAAGAT

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1261 CATCGAGATC CTGAACCACG ACAAGGACTA CAACAAGGTG ACCGTTTACG AGATCGCCGT

    1321 GGCCCGCAAC TCCACCGACG GCATGGACGA GCTGTACAAG TAA

    Multiple Cloning Sites

    C

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    11/17

    CMV Promoter ........ 1-595

    mWasabi GFP ........ 613-1320

    Multiple Cloning Sites ........ 1321-1414

    SV40 poly(A) Signal ........ 1560-1610

    PGK Promoter ........ 1688-2190Puromycin Resistance Gene ........ 2273-2872

    SV40 poly(A) signal ........ 2996-3222

    Ampicillin Resistance Gene ........ 3872-4732

    pUC Origin ........ 4881-5523

    Sequencing Primer:

    mWasabi-F(ABP-FP-WASFPRM)

    pmWasabi-NT-PuroR (ABP-FP-WNNCSP)

    Multiple Cloning Sites

    601 CCGGTCGCCA CCATGGTGAG CAAGGGCGAG GAGACCACAA TGGGCGTAAT CAAGCCCGAC

    661 ATGAAGATCA AGCTGAAGAT GGAGGGCAAC GTGAATGGCC ACGCCTTCGT GATCGAGGGC

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>1261 ACCGTTTACG AGATCGCCGT GGCCCGCAAC TCCACCGACG GCATGGACGA GCTGTACAAG

    T V Y E I A V A R N S T D G M D E L Y K

    1321 TCCGGACTCA GATCTCGAGT CGGATCCTCG AATTCGGTAC CCTCTAGACA AGCTTGCGGC CGCTAA

    S G L R S R V G S S N S V P S R Q A C G R

    BglII XhoI BamH1 EcoRI KpnI HindIII NotI

    N

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    12/17

    CMV Promoter ........ 1-589

    Multiple Cloning Sites ........ 591-646

    mTFP1 TFP ........ 653-1363

    SV40 poly(A) Signal ........ 1394-1620

    PGK Promoter ........ 1621-2123

    Puromycin Resistance Gene ........ 2206-2805

    SV40 poly(A) signal ........ 2929-3155

    Ampicillin Resistance Gene ........ 3560-4420

    pUC Origin ........ 4575-5194

    Sequencing Primer:

    CMV-F and mTFP1-R(ABP-FP-TFPRPRM)

    pmTFP1-CT-PuroR (ABP-FP-TCNCSP )

    Multiple Cloning Sites

    587 ATCCGCTAGCTCTAGACTGGATCCTCGAATTCGGTACCTCAAGCTTGCGGCCGCCTCGAGNheI XbaI BamHI EcoRI KpnI HindIII NotI XhoI

    647 GCCACCATGGTGAGCAAGGGCGAGGAGACCACAATGGGCGTAATCAAGCCCGACATGAAG

    707 ATCAAGCTGAAGATGGAGGGCAACGTGAATGGCCACGCCTTCGTGATCGAGGGCGAGGGC

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1247 TTTGTGGACCACCGCATCGAGATCCTGAACCACGACAAGGACTACAACAAGGTGACCGTT

    1307 TACGAGAGCGCCGTGGCCCGCAACTCCACCGACGGCATGGACGAGCTGTACAAGTAA

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    13/17

    CMV Promoter ........ 1-595

    mTFP1 TFP ........ 613-1320

    Multiple Cloning Sites ........ 1321-1414

    SV40 poly(A) Signal ........ 1560-1610

    PGK Promoter ........ 1688-2190

    Puromycin Resistance Gene ........ 2273-2872

    SV40 poly(A) signal ........ 2996-3222

    Ampicillin Resistance Gene ........ 3872-4732

    pUC Origin ........ 4881-5523

    Sequencing Primer:

    mTFP1-F(ABP-FP-TFPFPRM)

    Multiple Cloning Sites

    pmTFP1-NT-PuroR (ABP-FP-TNNCSP)

    601 CCGGTCGCCA CCATGGTGAG CAAGGGCGAG GAGACCACAA TGGGCGTAAT CAAGCCCGAC

    661 ATGAAGATCA AGCTGAAGAT GGAGGGCAAC GTGAATGGCC ACGCCTTCGT GATCGAGGGC

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1261 ACCGTTTACG AGAGCGCCGT GGCCCGCAAC TCCACCGACG GCATGGACGA GCTGTACAAG

    1321 TCCGGACTCA GATCTCGAGT CGGATCCTCG AATTCGGTAC CCTCTAGACA AGCTTGCGGC

    1381 CGCTAA

    N

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    14/17

    CMV Promoter ........ 1-589

    Multiple Cloning Sites ........ 591-646

    LanRFP........ 653-1363

    SV40 poly(A) Signal ........ 1532-1582

    PGK Promoter ........ 1660-2162

    Puromycin Resistance Gene ........ 2245-2844

    SV40 poly(A) signal ........ 2968-3194

    Ampicillin Resistance Gene ........ 3844-4704

    pUC Origin ........ 4853-5495

    Sequencing Primer:

    CMV-F and LanRFP-R(ABP-FP-RFPRPRM)

    pLanRFP-CT-PuroR (ABP-FP-RCNCSP)

    Multiple Cloning Sites

    541 ACGGTGGGAG GTCTATATAA GCAGAGCTGG TTTAGTGAAC CGTCAGATCC GCTAGCTCTA

    601 GACTGGATCC TCGAATTCGG TACCTCAAGC TTGCGGCCGC CTCGAGGCCA CCATGGTGAG

    661 CAAGGGCGAG GAGGATAACA TGGCCCCTCT CCCAGCAACC CACGATTTAC ACATCTCCGG

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1261 CGTGTTCCGC AAGGTGGAAC TCAAGCACAC CAAGACTGAG CTCAACTTCA AGCAGTGGCA

    1321 GAAGGCATTC CAGGACATCG CCGGCATGGA CGAGCTGTAC AAGTAA

    C

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    15/17

    CMV Promoter ........ 1-595

    LanRFP ........ 613-1323

    Multiple Cloning Sites ........ 1324-1377

    SV40 poly(A) Signal ........ 1554-1604

    PGK Promoter ........ 1682-2184

    Puromycin Resistance Gene ........ 2267-2866

    SV40 poly(A) signal ........ 2990-3216

    Ampicillin Resistance Gene ........ 3866-4726

    pUC Origin ........ 4875-5517

    Sequencing Primer:

    LanRFP-F(ABP-FP-RFPFPRM)

    Multiple Cloning Sites

    pLanRFP-NT-PuroR (ABP-FP-RNNCSP)

    601 CCGGTCGCCA CCATGGTGAG CAAGGGCGAG GAGGATAACA TGGCCCCTCT CCCAGCAACC

    661 CACGATTTAC ACATCTCCGG CTCAATCAAT GGACATGAGT TTGACTTGGA AGGCAGTGGC

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1261 CTCAACTTCA AGCAGTGGCA GAAGGCATTC CAGGACATCG CCGGCATGGA CGAGCTGTAC

    1321 AAGAGATCTC GAGTCGGATC CTCGAATTCG GTACCCTCTA GACAAGCTTG CGGCCGCTAA

    N

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    16/17

    CMV Promoter ........ 1-589

    Multiple Cloning Sites ........ 591-646

    LanYFP ........ 653-1363

    SV40 poly(A) Signal ........ 1529-1579

    PGK Promoter ........ 1657-2159

    Puromycin Resistance Gene ........ 2242-2841

    SV40 poly(A) signal ........ 2965-3191

    Ampicillin Resistance Gene ........ 3841-4701

    pUC Origin ........ 4850-5492

    Sequencing Primer:

    CMV-F and LanYFP-R(ABP-FP-YFPRPRM)

    pLanYFP-CT-PuroR (ABP-FP-YCNCSP)

    Multiple Cloning Sites

    541 ACGGTGGGAG GTCTATATAA GCAGAGCTGG TTTAGTGAAC CGTCAGATCC GCTAGCTCTA

    601 GACTGGATCC TCGAATTCGG TACCTCAAGC TTGCGGCCGC CTCGAGGCCA CCATGGTGAG

    661 CAAGGGCGAG GAGGATAACA TGGCCTCTCT CCCAGCGACA CATGAGTTAC ACATCTTTGG

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1261 GTTCCGTAAG ACGGAGCTCA AGCACTCCAA GACCGAGCTC AACTTCAAGG AGTGGCAAAA

    1321 GGCCTTTACC GATGTGATGG GCATGGACGA GCTGTACAAG TAA

    C

  • 8/8/2019 Fluorescent Protein Fusion Expression System

    17/17

    CMV Promoter ........ 1-595

    LanYFP ........ 613-1323

    Multiple Cloning Sites ........ 1324-1377

    SV40 poly(A) Signal ........ 1554-1604

    PGK Promoter ........ 1682-2184

    Puromycin Resistance Gene ........ 2267-2866

    SV40 poly(A) signal ........ 2990-3216

    Ampicillin Resistance Gene ........ 3866-4726

    pUC Origin ........ 4875-5517

    Sequencing Primer:

    LanYFP-F(ABP-FP-YFPFPRM)

    Multiple Cloning Sites

    pLanYFP-NT-PuroR (ABP-FP-YNNCSP)

    661 CCGGTCGCCA CCATGGTGAG CAAGGGCGAG GAGGATAACA TGGCCTCTCT CCCAGCGACA

    721 CATGAGTTAC ACATCTTTGG CTCCTTCAAC GGTGTGGACT TTGACATGGT GGGTCGTGGC

    >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

    1321AACTTCAAGG AGTGGCAAAA GGCCTTTACC GATGTGATGG GCATGGACGA GCTGTACAAG

    1381 AGATCTCGAG TCGGATCCTC GAATTCGGTA CCCTCTAGAC AAGCTTGCGG CCGCTAA

    N